D-Wave Quantum Inc. (NYSE: QBTS) and Japan Tobacco Complete Quantum AI Project Designed to Improve Drug Discovery Outcomes
D-Wave and Japan Tobacco’s pharmaceutical division completed a proof-of-concept project aimed at speeding up and improving the design of small molecule pharmaceuticals. D-Wave’s annealing quantum computer was used to train large language models within Japan Tobacco’s AI framework. The quantum-hybrid application outperformed classical methods in generating valid and drug-like molecules. Japan Tobacco plans to further pursue Quantum AI in molecular design following these early results. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”), have announced the successful completion of a proof-of-concept project applying quantum…